A Phase 1 Study of BPI-371153 in Subjects with Advanced Solid Tumors or Relapsed/Refractory Lymphoma
- Status
- RECRUITING
- Phase
- PHASE1
Clinical Trials Related to NSCLC
Related studies linked through entity extraction aliases.
Using Ex Vivo Tumoroids To Predict Immunotherapy Response In NSCLC
- Status
- RECRUITING
- Phase
- N/A
A Safety, Tolerability, PK and Preliminary Activity Study of GB263T in Advanced NSCLC and Other Solid Tumor
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
MRD-guided Adjuvant Tislelizumab and Chemotherapy in Resected Stage IIA-IIIB NSCLC
- Status
- RECRUITING
- Phase
- PHASE2
Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Lazertinib for Patients With NSCLC Harboring Uncommon EGFR Mutations
- Status
- UNKNOWN
- Phase
- PHASE2
A Study to Investigate LYL797 in Adults With Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Effect of Neoadjuvant Anti-PD-1 Immunotherapy on Perioperative Analgesia and Postoperative Delirium
- Status
- COMPLETED
- Phase
- N/A
RW Efficacy of Sotorasib in KRAS G12C-mutated Metastatic NSCLC
- Status
- UNKNOWN
- Phase
- N/A
Glycan Mediated Immune Regulation With a Bi-Sialidase Fusion Protein (GLIMMER-01)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Phase 1/2 Study of Silevertinib (BDTX-1535) in Patients With Glioblastoma or Non-Small Cell Lung Cancer With EGFR Mutations
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
PRIME_LUNG: Primary Radiotherapy In MEtastatic Lung Cancer - A Pilot Study
- Status
- RECRUITING
- Phase
- PHASE1
Alflutinib Versus Alflutinib Plus Chemotherapy for NSCLC
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3
Clinical Trial of GAIA-102 for Advanced and Relapse NSCLC
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Phase 1/2 Study of BA3071 in Patients With Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Adjuvant Targeted-therapy for Patients With Resected High-risk EGFR-mutant Stage IB-IIA Non-small Cell Lung Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE2
Residual Disease Evaluation of Resected NSCLC by cirDNA Analysis
- Status
- COMPLETED
- Phase
- NA
Crizotinib Continuation Clinical Study
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE4
Study of TY-9591 in Patients With a Lung Cancer With Brain or Leptomeningeal Metastases With EGFR Mutation
- Status
- COMPLETED
- Phase
- PHASE2
Lorlatinib Continuation Study
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE4